https://pharmadog.xyz/news/605227 pharmadog en 2026-10-28T12:29:20.000Z Astellas signs up to $1.34 billion option deal for Audax's DAX-044 immuno-oncology candidate https://pharmadog.xyz/news/605228 pharmadog en 2026-10-28T12:12:06.000Z Biogen posts third consecutive quarter of revenue growth, driven by Leqembi, Spinraza and Apellis products https://pharmadog.xyz/news/605247 pharmadog en 2026-10-28T12:01:13.000Z U.S. overdose deaths fell 27% in 2024, with early 2025 data showing further decline https://pharmadog.xyz/news/123087 pharmadog en 2026-10-28T11:26:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/604911 pharmadog en 2026-10-28T10:45:00.000Z Lilly's retatrutide outperforms Ozempic in weight loss and blood sugar reduction in head-to-head diabetes trial https://pharmadog.xyz/news/604868 pharmadog en 2026-10-28T10:26:20.000Z Astellas secures exclusive option on Audax Biosciences preclinical IL-12 cancer drug https://pharmadog.xyz/news/604891 pharmadog en 2026-10-28T10:15:39.000Z Merck and Moderna vaccine data leak ahead of ESMO, Merck's sac-TMT cuts endometrial cancer deaths, BMS reports CAR-T death https://pharmadog.xyz/news/604578 pharmadog en 2026-10-28T08:30:00.000Z Epic's data‑blocking tactics curb health‑tech innovation, investigation finds https://pharmadog.xyz/news/604576 pharmadog en 2026-10-28T08:30:00.000Z STAT seeks input on how Epic's practices affect hospital technology choices https://pharmadog.xyz/news/604575 pharmadog en 2026-10-28T08:30:00.000Z Pediatricians work to calm families and promote MMR vaccination amid Pennsylvania measles outbreak https://pharmadog.xyz/news/604577 pharmadog en 2026-10-28T08:30:00.000Z Physician's personal egg-freezing story highlights systemic sexism in fertility industry https://pharmadog.xyz/news/605178 pharmadog en 2026-10-28T07:46:00.000Z Lilly's retatrutide outperforms Ozempic in phase 3 trial, cutting blood sugar and weight more https://pharmadog.xyz/news/605010 pharmadog en 2026-10-28T06:34:00.000Z GSK says UK restructuring will have limited impact on staff, focusing cuts on support roles https://pharmadog.xyz/news/605012 pharmadog en 2026-10-28T05:38:00.000Z Astellas commits up to $285M upfront for Audax's preclinical IL-12 program, with potential $1.05B milestones https://pharmadog.xyz/news/603775 pharmadog en 2026-10-28T04:24:00.000Z Five newly approved drugs achieve strong launches by offering superior efficacy, pricing and access https://pharmadog.xyz/news/603776 pharmadog en 2026-10-28T04:24:00.000Z Big pharma holds $188 bn for M&A, J&J seen as most likely buyer, analysis shows https://pharmadog.xyz/news/603777 pharmadog en 2026-10-28T04:01:00.000Z Biopharma leader urged to prioritize own job search after team layoffs https://pharmadog.xyz/news/603778 pharmadog en 2026-10-28T04:01:00.000Z Former Novo and Sanofi staff describe mixed layoff experiences, citing severance benefits and poor communication https://pharmadog.xyz/news/603779 pharmadog en 2026-10-28T04:01:00.000Z Biotech firms must adopt global regulatory strategies to commercialize drugs independently https://pharmadog.xyz/news/602635 pharmadog en 2026-10-27T22:31:54.000Z Anthropic acquires one-person biotech Mithril Medicine to expand into life sciences https://pharmadog.xyz/news/602191 pharmadog en 2026-10-27T20:52:03.000Z Mennonite family backs new gene-therapy startup https://pharmadog.xyz/news/601855 pharmadog en 2026-10-27T18:50:49.000Z US Treasury draft COINS rules could sharply limit China biotech partnerships https://pharmadog.xyz/news/601899 pharmadog en 2026-10-27T18:45:34.000Z Missouri AG orders Eli Lilly to stop demanding hospital data for 340B discounts https://pharmadog.xyz/news/601856 pharmadog en 2026-10-27T18:23:59.000Z U.S. judge rejects Novo Nordisk's bid to block Eli Lilly obesity drug ads https://pharmadog.xyz/news/601978 pharmadog en 2026-10-27T18:18:00.000Z Taylor Farms recalls H-EB Backyard BBQ Chop Salad Kit over possible undeclared soy and almonds https://pharmadog.xyz/news/601455 pharmadog en 2026-10-27T16:17:33.000Z FDA releases details on accelerated approval process for personalized gene therapies https://pharmadog.xyz/news/601475 pharmadog en 2026-10-27T16:03:00.000Z Federal judge denies Novo's attempt to block Eli Lilly obesity drug ads https://pharmadog.xyz/news/601287 pharmadog en 2026-10-27T15:45:21.000Z RFK Jr. campaigns in Iowa as healthcare companies prepare earnings reports https://pharmadog.xyz/news/601243 pharmadog en 2026-10-27T15:21:31.000Z Gubra aims to expand beyond obesity drugs, targets first portfolio partner this year https://pharmadog.xyz/news/601366 pharmadog en 2026-10-27T15:15:00.000Z Haifa Smoked Fish recalls 560 lbs of cold-smoked sprats over possible Clostridium botulinum contamination https://pharmadog.xyz/news/134233 pharmadog en 2026-10-27T14:50:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/601075 pharmadog en 2026-10-27T14:45:41.000Z Artiva Biotherapeutics to cease operations after two deaths in autoimmune cell therapy trials https://pharmadog.xyz/news/601076 pharmadog en 2026-10-27T14:38:38.000Z Outpace Bio halts Phase 1 ovarian cancer CAR‑T trial https://pharmadog.xyz/news/601119 pharmadog en 2026-10-27T14:28:10.000Z Nonprofit revives gene therapy program after UK startup closure https://pharmadog.xyz/news/601100 pharmadog en 2026-10-27T14:07:14.000Z Incyte's KRAS G12D inhibitor shows 89% response rate in early pancreatic cancer trial https://pharmadog.xyz/news/601077 pharmadog en 2026-10-27T14:04:06.000Z Biopharma optimism climbs after FDA commissioner Makary's exit, survey finds https://pharmadog.xyz/news/600931 pharmadog en 2026-10-27T13:45:01.000Z Alphabet’s GV tops biotech corporate investors with $5.23 billion in deals since 2025 https://pharmadog.xyz/news/600951 pharmadog en 2026-10-27T13:25:50.000Z U.S. judge denies effort to block Eli Lilly's weight-loss ad; GSK reports oncology drug approval https://pharmadog.xyz/news/600907 pharmadog en 2026-10-27T13:16:29.000Z Ferring agrees to buy fertility startup Gameto in deal up to $1.38 billion https://pharmadog.xyz/news/600932 pharmadog en 2026-10-27T13:13:57.000Z Novartis takes $1.9B write-down after Avidity's del-desiran fails Phase 3 but reaffirms confidence in $12B acquisition https://pharmadog.xyz/news/600675 pharmadog en 2026-10-27T12:22:28.000Z Researchers isolate marine compound that may halt deadly brain-eating amoeba infections https://pharmadog.xyz/news/600295 pharmadog en 2026-10-27T10:57:52.000Z Novartis reaffirms $12 billion Avidity acquisition despite $1.9 billion impairment loss https://pharmadog.xyz/news/600296 pharmadog en 2026-10-27T10:34:44.000Z Novartis weighs private-pay launches in Europe as MFN rules pressure government pricing https://pharmadog.xyz/news/600714 pharmadog en 2026-10-27T08:40:00.000Z Artiva Biotherapeutics cuts 94% of workforce after patient deaths and failed autoimmune cell therapy https://pharmadog.xyz/news/600004 pharmadog en 2026-10-27T08:30:00.000Z Phase 3 trial shows cancer vaccine intismeran autogene cuts recurrence risk by 42% versus Keytruda https://pharmadog.xyz/news/600005 pharmadog en 2026-10-27T08:30:00.000Z Pennsylvania Mennonite community creates its own biotech firm after successful gene therapy in a calf with maple syrup urine disease https://pharmadog.xyz/news/600003 pharmadog en 2026-10-27T08:30:00.000Z Pediatric emergency departments remain in chronic crisis after 2022 tripledemic, says opinion piece https://pharmadog.xyz/news/600438 pharmadog en 2026-10-27T07:37:00.000Z Aspen Neuroscience and Bambusa Therapeutics each target $134 million IPOs https://pharmadog.xyz/news/600883 pharmadog en 2026-10-27T06:35:00.000Z Leak of Moderna-Merck cancer vaccine phase 3 data sparks drama at ESMO 2026 conference https://pharmadog.xyz/news/601958 pharmadog en 2026-10-27T04:00:00.000Z FDA issues early alert on B. Braun Streamline Bloodline Set recall due to connector leak risk https://pharmadog.xyz/news/600272 pharmadog en 2026-10-27T03:51:00.000Z Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran fail https://pharmadog.xyz/news/599934 pharmadog en 2026-10-27T03:30:00.000Z GSK's B7-H3 ADC cuts osteosarcoma progression risk by 67% in Chinese phase 3 trial https://pharmadog.xyz/news/601222 pharmadog en 2026-10-27T02:37:00.000Z Labcorp acquires Millennium Health to expand toxicology testing nationwide https://pharmadog.xyz/news/602709 pharmadog en 2026-10-27T00:00:00.000Z FDA officials share guidance on de novo device classifications and upcoming MDUFA VI changes at MedTech Conference https://pharmadog.xyz/news/602710 pharmadog en 2026-10-27T00:00:00.000Z FDA releases draft guidance on oversight of individualized gene-editing products https://pharmadog.xyz/news/602711 pharmadog en 2026-10-27T00:00:00.000Z FDA approves prostate cancer and Crohn’s disease therapies as judge rejects effort to block Lilly weight‑loss ads https://pharmadog.xyz/news/598275 pharmadog en 2026-10-26T23:17:13.000Z Roche's KRAS inhibitor divarasib shows strong results in second-line lung cancer trial at ESMO https://pharmadog.xyz/news/597939 pharmadog en 2026-10-26T21:54:24.000Z Bon Secours Mercy Health to Acquire Surgery Partners in $5.7 B Deal, Expanding Ambulatory Surgery Network https://pharmadog.xyz/news/597831 pharmadog en 2026-10-26T21:16:11.000Z HHS rolls back 14 security and privacy requirements for EHR certification https://pharmadog.xyz/news/597619 pharmadog en 2026-10-26T20:50:03.000Z Employers sue UnitedHealth, alleging overpayment of workers' medical claims https://pharmadog.xyz/news/597475 pharmadog en 2026-10-26T19:50:59.000Z U.S. biotechs capture 68% of global VC funding since 2025, led by Bay Area and Boston https://pharmadog.xyz/news/597515 pharmadog en 2026-10-26T19:17:00.000Z Corxel to go public via $300 million SPAC merger, advancing GLP-1 pill CX11 and amylin candidate https://pharmadog.xyz/news/597451 pharmadog en 2026-10-26T19:00:50.000Z Microsoft AI twice as accurate as doctors in diagnosing cases, study shows https://pharmadog.xyz/news/597115 pharmadog en 2026-10-26T17:43:52.000Z WuXi AppTec lifts 2026 revenue outlook despite US defense designation dispute https://pharmadog.xyz/news/596883 pharmadog en 2026-10-26T16:26:50.000Z House lawmaker probes PBMs over alleged punitive audits of independent pharmacies https://pharmadog.xyz/news/596884 pharmadog en 2026-10-26T16:20:05.000Z GSK gains another cancer drug approval and unveils promising chemo data as it prepares for lung cancer approval https://pharmadog.xyz/news/596839 pharmadog en 2026-10-26T16:06:38.000Z Roche delays European filing of breast-cancer pill giredestrant amid US pricing pressures https://pharmadog.xyz/news/596904 pharmadog en 2026-10-26T15:58:00.000Z Melanoma vaccine shows 42% risk reduction at ESMO 2026, but shares tumble on early data release https://pharmadog.xyz/news/596671 pharmadog en 2026-10-26T15:49:12.000Z Merck highlights oncology pipeline and cancer vaccine trial at ESMO 2026 https://pharmadog.xyz/news/600102 pharmadog en 2026-10-26T15:48:00.000Z Corxel opts for SPAC merger to take oral obesity drug public on Nasdaq https://pharmadog.xyz/news/596715 pharmadog en 2026-10-26T15:30:00.000Z Merck/Kelun ADC sac-TMT cuts death risk by one-third in advanced endometrial cancer https://pharmadog.xyz/news/596696 pharmadog en 2026-10-26T15:01:29.000Z J&J's Halda-derived prostate cancer drug shows 75% response in early Phase 1 trial https://pharmadog.xyz/news/596503 pharmadog en 2026-10-26T14:40:47.000Z Aspen Neuroscience and Bambusa Therapeutics each aim for $135 million IPOs https://pharmadog.xyz/news/596527 pharmadog en 2026-10-26T14:40:40.000Z Biotech IPOs Pull in $7.5B Across 22 Deals in 2026, While Market Gains Stall in Q3 https://pharmadog.xyz/news/596547 pharmadog en 2026-10-26T14:38:28.000Z Health insurance premiums surge as CMS ramps up Medicaid fraud crackdown https://pharmadog.xyz/news/596528 pharmadog en 2026-10-26T14:33:05.000Z Merck and Moderna's mRNA melanoma vaccine shows 42% risk reduction in Phase 3 trial, easing analyst concerns https://pharmadog.xyz/news/596529 pharmadog en 2026-10-26T14:29:08.000Z Amgen’s Imdelltra plus AstraZeneca’s Imfinzi cuts death risk by ~60% in extensive-stage small cell lung cancer